carbapenems has been researched along with methicillin in 12 studies
Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (methicillin) | Trials (methicillin) | Recent Studies (post-2010) (methicillin) |
---|---|---|---|---|---|
7,355 | 147 | 5,277 | 4,375 | 72 | 1,046 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (41.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (16.67) | 29.6817 |
2010's | 3 (25.00) | 24.3611 |
2020's | 2 (16.67) | 2.80 |
Authors | Studies |
---|---|
Andrews, JM; Ashby, JP; Wise, R | 1 |
Dornbusch, K; Göransson, E; Kronvall, G; Mörtsell, E | 1 |
Piddock, LJ; Traynor, EA; Wise, R | 1 |
Hadorn, K; Kayser, FH; Morenzoni, G; Strässle, A | 1 |
Bywater, MJ; Holt, HA; Reeves, DS | 1 |
Bowker, KE; MacGowan, AP; Noel, AR | 1 |
Appelbaum, PC; Glupczynski, Y; Lemaire, S; Olivier, A; Tulkens, PM; Van Bambeke, F | 1 |
Aleksandrova, IV; Borisova, LA; Chernen'kaia, TV; Kosolapov, DA; Nikitina, OV; Reĭ, SI | 1 |
Cornaglia, M; Gijs, MAM; Hernández-Neuta, I; Kühnemund, M; Nilsson, M; Sharif, MI | 1 |
Aurilio, C; Borgia, G; Fiore, M; Gentile, I; Leone, S; Maraolo, AE; Pace, MC; Passavanti, MB; Sansone, P | 1 |
Brooks, L; Kaze, M; Sistrom, M | 1 |
Hrynchuk, OB; Ishchak, OM; Kolesnik, AV; Rud, VO; Salmanov, AG; Terekhov, VA; Voloshynovych, NS | 1 |
1 review(s) available for carbapenems and methicillin
Article | Year |
---|---|
Nosocomial spontaneous bacterial peritonitis antibiotic treatment in the era of multi-drug resistance pathogens: A systematic review.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Carbapenems; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Hospitals; Humans; Liver Cirrhosis; Methicillin; Methicillin-Resistant Staphylococcus aureus; Peritonitis; Practice Guidelines as Topic; Pseudomonas aeruginosa; Treatment Outcome; Vancomycin-Resistant Enterococci | 2017 |
11 other study(ies) available for carbapenems and methicillin
Article | Year |
---|---|
The antibacterial activity of meropenem in combination with gentamicin or vancomycin.
Topics: Carbapenems; Colony Count, Microbial; Culture Media; Drug Therapy, Combination; Gentamicins; Kinetics; Meropenem; Methicillin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Thienamycins; Vancomycin | 1989 |
Comparative in-vitro activity of the penem FCE 22101 against recent European blood culture isolates.
Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Gram-Negative Bacteria; Humans; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Pseudomonas; Sepsis; Staphylococcus | 1989 |
Activity of FCE 22101 against methicillin-resistant Staphylococcus aureus and affinity for penicillin binding proteins.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Carrier Proteins; Hexosyltransferases; Imipenem; Methicillin; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin Resistance; Penicillin-Binding Proteins; Peptidyl Transferases; Staphylococcus aureus | 1989 |
Activity of meropenem, against gram-positive bacteria.
Topics: Bacterial Proteins; Carbapenems; Carrier Proteins; Gram-Positive Bacteria; Hexosyltransferases; Meropenem; Methicillin; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin Resistance; Penicillin-Binding Proteins; Penicillinase; Peptidyl Transferases; Staphylococcus aureus; Thienamycins | 1989 |
Activity of penems against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Microbial; Imipenem; Lactams; Methicillin; Microbial Sensitivity Tests; Staphylococcus aureus | 1988 |
Pharmacodynamics of the antibacterial effect and emergence of resistance to tomopenem, formerly RO4908463/CS-023, in an in vitro pharmacokinetic model of Staphylococcus aureus infection.
Topics: Anti-Bacterial Agents; Carbapenems; Colony Count, Microbial; Drug Resistance, Bacterial; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin | 2008 |
Restoration of susceptibility of intracellular methicillin-resistant Staphylococcus aureus to beta-lactams: comparison of strains, cells, and antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefepime; Cefuroxime; Cell Line; Cells, Cultured; Cephalosporins; Cloxacillin; Humans; Hydrogen-Ion Concentration; Imipenem; Meropenem; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Phagocytosis; Staphylococcus aureus; Thienamycins | 2008 |
[Pattern dynamics of bacteriemia and sepsis pathogens in ICU patients of emergency service].
Topics: Acetamides; Acinetobacter; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Candida; Candidiasis; Carbapenems; Cefoperazone; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Klebsiella pneumoniae; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Sepsis; Sulbactam; Vancomycin | 2013 |
Sensitive and inexpensive digital DNA analysis by microfluidic enrichment of rolling circle amplified single-molecules.
Topics: Anti-Bacterial Agents; beta-Lactamases; Biosensing Techniques; Carbapenems; Carbocyanines; Dimethylpolysiloxanes; DNA Probes; DNA, Circular; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Proteins; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Gene Expression; Humans; Lab-On-A-Chip Devices; Methicillin; Microscopy, Fluorescence; Mutation; Oligonucleotides; Polymerase Chain Reaction; Pseudomonas aeruginosa; Staphylococcus aureus | 2017 |
Genomic Sequence Analysis of Methicillin- and Carbapenem-Resistant Bacteria Isolated from Raw Sewage.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Proteins; Carbapenems; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Genomics; Methicillin; Plasmids; Sewage; Water Purification | 2021 |
HEALTHCARE-ASSOCIATED TUBO-OVARIAN INFECTIONS IN UKRAINE: RESULTS OF A MULTICENTER STUDY (2020-2022).
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cohort Studies; Cross Infection; Delivery of Health Care; Drug Resistance, Bacterial; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Methicillin; Pseudomonas aeruginosa; Staphylococcus aureus; Ukraine; Vancomycin | 2022 |